In an exploratory study in cats, tumors had a lower pH than healthy muscle in the same animals, indicating greater acidity. The images also showed a trend toward greater acidity in higher-grade fibrosarcomas. The study was small, included very different tumors, and was not blinded at any stage. The cats’ FeLV status was not reported, and these results do not demonstrate the same findings in FeLV-associated lymphoma or leukemia.
Scientific detail
This exploratory in vivo pilot study, published in Advanced Science in 2026 (doi: 10.1002/advs.77830), examined feline mesenchymal tumors using hyperpolarized 13C MRI and PET. The results describe 17 patients with biopsy-confirmed malignant mesenchymal neoplasms and one patient with a benign neurofibroma. The supplied passage does not report the sample size for the paired tumor-versus-muscle pH comparison. The methods report follow-up surveys completed by nine owners and overall survival information obtained for one patient at a follow-up visit.
Within this cohort, measured tumor pH was lower than healthy muscle pH in the same animals. The imaging data also showed a trend toward greater acidification with higher fibrosarcoma grade. Both statements are classified as level C evidence in the supplied object. The paired comparison supports relative tumor acidification in this preliminary cohort but does not establish that acidity causes malignancy. The grade-related trend is neither a validated grading biomarker nor evidence of a causal relationship between acidity and tumor progression.
When a voxel contains multiple pH compartments, the reported measurement averages the detected compartments, weighting them by their spectral peak intensities. It should not be interpreted as a separately resolved extracellular pH measurement in every voxel. This description of the measurement is classified as level C evidence.
No stage of the study was blinded, a design limitation classified as level C evidence that does not itself demonstrate bias in any particular measurement. The cohort was highly heterogeneous; intersubject muscle pH variation was observed, and systemic pH was noted to be susceptible to isoflurane anesthesia. A bimorphic tumor could not be precisely subtyped because feline tissue-specific markers were lacking. The authors make biomarker development conditional on validation in larger cohorts. Discussion-specific limitations cannot be extracted because that section is effectively unavailable in the supplied text.
The supplied text concerns mesenchymal tumors, not FeLV-associated lymphoma or leukemia, and reports neither FeLV infection status nor viral oncogenesis. Its relevance to the ONCOLOGY LAB is methodological: it provides an approach to imaging the feline tumor microenvironment. The need for separate validation before extending it to FeLV-associated malignancies is an inference, not a study finding; it does not establish that the workflow succeeds or fails in those diseases.
What we know
Level C evidence supports lower tumor pH than healthy muscle pH in a within-animal comparison and a trend toward greater acidification with higher fibrosarcoma grade. The study was exploratory, highly heterogeneous, and unblinded. Its pH measurement combines detected compartments within a voxel using spectral peak intensity weighting.
What we don't know
The number of cats in the paired pH comparison and their FeLV infection status are not reported. Acidity has not been established as a cause of malignancy or tumor progression, and no viral mechanism has been identified. Whether these findings or this workflow apply to FeLV-associated lymphoma or leukemia is unknown. Biomarker development requires validation in larger cohorts. Discussion-specific limitations cannot be assessed from the supplied text.
Evidence
EvidenceLevel C — Preliminary evidenceConfidence 100/100
In this exploratory feline tumor cohort, measured tumor pH was lower than healthy muscle pH within the same animals.
Excerpt verified in the source — verbatim, in the source's own language“In addition, a comparison of tumor pH to healthy tissue pH from the same animals also revealed tumor acidification (pH 7.30 ± 0.18) compared to muscle pH (paired t ‐test, pH 7.41 ± 0.11, p = 0.001, Figure 3D ).”
The paired comparison supports relative tumor acidification in this preliminary cohort. It does not establish that acidity causes malignancy, identify a viral mechanism, or demonstrate the same finding in FeLV-associated lymphoma or leukemia. The supplied passage does not identify the meaning of the ± values or the number of evaluable pairs.
EvidenceLevel C — Preliminary evidenceConfidence 100/100
The imaging data showed a trend toward greater acidification with higher fibrosarcoma grade.
Excerpt verified in the source — verbatim, in the source's own language“Here, FSs of different grades can show acidification of up to 0.5 pH units (Figure 3E ), with a trend to higher acidification for higher FS grade.”
The source describes a trend in a preliminary heterogeneous cohort, not a validated grading biomarker or a causal link between acidity and tumor progression. This does not establish a relationship with FeLV-mediated oncogenesis.
EvidenceLevel C — Preliminary evidenceConfidence 100/100
No stage of this exploratory pilot study was blinded.
Excerpt verified in the source — verbatim, in the source's own language“No blinding was applied at any stage because of the explorative nature of this pilot study.”
This is an explicitly reported design limitation. It warrants caution when interpreting exploratory imaging and outcome associations but does not itself show that any particular measurement was biased.
EvidenceLevel C — Preliminary evidenceConfidence 100/100
The reported pH measurement averages detected pH compartments using their spectral peak intensities as weights when a voxel contains multiple compartments.
Excerpt verified in the source — verbatim, in the source's own language“For voxels containing more than one pH compartment, mean pH values, only reported as pH throughout this study, were averaged using the peak intensities as weights.”
This defines the study's reported pH readout and matters when interpreting heterogeneous tumor tissue. It should not be interpreted as a separately resolved extracellular pH measurement for every voxel.
InferenceConfidence 95/100
Extending this sarcoma imaging workflow to FeLV-associated lymphoma or leukemia would require separate validation.
This inference follows from the mesenchymal-tumor enrollment criteria and the absence of reported FeLV status or hematologic malignancies in the supplied text. It is not a finding that the workflow succeeds or fails in FeLV-associated disease.
Provenance
Source: Multimodal Imaging of Hypoxia, Metabolism and pH in Feline Sarcoma Using Hyperpolarized <sup>13</sup>C MRI and PET.
AVA